2019
DOI: 10.1016/j.phymed.2019.152938
|View full text |Cite
|
Sign up to set email alerts
|

Tylophorine reduces protein biosynthesis and rapidly decreases cyclin D1, inhibiting vascular smooth muscle cell proliferation in vitro and in organ culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…16 Additionally, numerous studies have demonstrated that targeting CCND1 is useful for treating neointimal formation. 9,17,18 The Wnt genes were first characterized in 1978 in mutant wingless Drosophila melanogaster. 19 Since then, the Wnt family has been implicated in a myriad of physiological processes, including cell proliferation, differentiation, and migration.…”
Section: Discussionmentioning
confidence: 99%
“…16 Additionally, numerous studies have demonstrated that targeting CCND1 is useful for treating neointimal formation. 9,17,18 The Wnt genes were first characterized in 1978 in mutant wingless Drosophila melanogaster. 19 Since then, the Wnt family has been implicated in a myriad of physiological processes, including cell proliferation, differentiation, and migration.…”
Section: Discussionmentioning
confidence: 99%
“…Tylophorine ( 1 ) potently inhibited the PDGF-BB-induced proliferation of rat aortic vascular smooth muscle cells (VSMCs) in a concentration-dependent manner with an IC 50 of 0.13 µM, by arresting cells in G1 phase of the cell cycle as well as migration in activated VSMCs. It could decrease de novo protein synthesis, result in downregulation of cyclin D1 and prevent neointimal thickening in human saphenous vein organ culture (Joa et al 2019 ). Anti-angiogenic results indicated tylophorine ( 1 ) and antofine ( 2 ) could be used as promising lead compounds for further studies towards the treatment of vasculo-proliferative disorders, such as restenosis.…”
Section: Antiviral Activitymentioning
confidence: 99%
“…The properties and bioactivities of tylophorine has been well investigated (Table 1). Tylophorine possesses antiproliferative action in cancer cells; it rapidly diminishes cyclin D1, reduces protein biosynthesis and prevents vascular smooth muscle cell proliferation in vitro (Joa et al 2019). Apoptosis could be mediated by unique application of tylophorine or tylophorine plus doxorubicin in T47D breast cancer cells; this happened because it regulated the expression of genes of caspases 3 and 9 (Pratama et al 2018).…”
Section: Bioactive Properties and Application Of Tylophorinementioning
confidence: 99%